CIK: 1110748 - Address: C/o Eyepoint Pharmaceuticals, Inc., 480 Pleasant Street, Watertown, MA 02472
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret11122155657616664
P%wins100100100100100100100

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

8/21/24 16:01
8/21/24
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumAndo GoranMADP407.95056113D
2/13/23 17:04
2/9/23
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumAndo GoranMADM.d00.0003668D
2/11/22 16:48
2/9/22
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumAndo GoranMADM.d00.00031285D
3/2/21 19:24
2/28/21
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumAndo GoranMADM.d00.0002New2D
7/6/09 16:52
7/2/09
ENZNEnzon Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagAndo GoranNJDM.dm00.00341240D-1734269-42-1131053432
11/17/08 14:46
11/14/08
ENZNEnzon Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagAndo GoranNJDP573.772157136D-53-60-56-58-35-13-217221556576166
7/3/08 16:02
7/1/08
ENZNEnzon Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagAndo GoranNJDM.dm00.00363521D-2-7-21-22-17-8-51-1-214-3-225
7/3/07 16:03
7/1/07
ENZNEnzon Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagAndo GoranNJDM.dm00.0062845D205-6-2-7-7-6-2-1-3-101320-9
7/5/06 13:46
7/1/06
ENZNEnzon Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagAndo GoranNJDM.d00.0071803D-40142-64133016894

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact